Yahoo
    NYSE - Delayed Quote USD

    DaVita Inc. (DVA)

    183.93 +2.24 (+1.23%)
    At close: October 28 at 4:00:02 PM EDT
    181.45 -2.48 (-1.35%)
    Pre-Market: 4:34:22 AM EDT
    Trade DaVita on Coinbase
    DVA Q3 2026 earnings call
    Today at 5 PM EDT
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for DVA

    What's happening with DVA?

    30m ago     Powered by Yahoo Scout

    DaVita is scheduled to report third-quarter 2026 results after the market closes on October 29. Expectations center on strong earnings growth, modest revenue growth, improving treatment volumes, and risks from payer mix, revenue per treatment, and healthcare-cost pressures.

    Powered by Yahoo Scout
    • Previous Close 181.69
    • Open 181.00
    • Bid 176.00 x 20000
    • Ask 195.00 x 20000
    • Day's Range 181.45 - 184.53
    • 52 Week Range 101.00 - 247.49
    • Volume 439,066
    • Avg. Volume 780,118
    • Market Cap (intraday) 11.735B
    • Beta (5Y Monthly) 0.80
    • PE Ratio (TTM) 15.53
    • EPS (TTM) 11.84
    • Earnings Date Oct 29, 2026
    • Forward Dividend & Yield -- (0.00%)
    • 1y Target Est 219.86
    • Morningstar Rating Rating available with Stock Picks access

    DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

    www.davita.com

    78,000

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Medical Care Facilities

    Industry

    More about DaVita Inc.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 10/28/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

    YTD Return

    DVA
    61.90%
    S&P 500 (^GSPC)
    13.13%

    1-Year Return

    DVA
    41.91%
    S&P 500 (^GSPC)
    12.38%

    3-Year Return

    DVA
    139.59%
    S&P 500 (^GSPC)
    88.08%

    5-Year Return

    DVA
    61.20%
    S&P 500 (^GSPC)
    68.48%

    Earnings Trends

    View More

    Earnings Per Share

    GAAP
    Normalized
    GAAP
    Normalized

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q1 FY26
    Revenue 3.42B
    Earnings 197.53M
    Profit Margin 5.78%

    Q2

    FY25

    Q3

    FY25

    Q4

    FY25

    Q1

    FY26

    0
    1B
    2B
    3B
    4.5%
    5.0%
    5.5%
    6.0%
    View More

    Analyst Insights

    View More

    Analyst Price Targets

    165.00 Low
    219.86 Average
    183.93 Current
    270.00 High

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell

    Latest Rating

    Date 8/7/2026
    Analyst TD Cowen
    Rating Action Upgrade
    Rating Buy
    Price Action Lowers
    Price Target 201 -> 220
    View More

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      6.05%

    • Return on Assets (ttm)

      7.51%

    • Return on Equity (ttm)

      88.48%

    • Revenue (ttm)

      14.01B

    • Net Income Avi to Common (ttm)

      822.48M

    • Diluted EPS (ttm)

      11.84

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      688.88M

    • Total Debt/Equity (mrq)

      1,241.99%

    • Levered Free Cash Flow (ttm)

      1.04B

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    MCO Moody's Corporation
    477.27 +0.69%
    UHS Universal Health Services, Inc.
    172.18 -2.90%
    DGX Quest Diagnostics Incorporated
    245.62 +1.26%
    LH Labcorp Holdings Inc.
    360.25 +8.78%
    HCA HCA Healthcare, Inc.
    463.22 +2.95%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: